Page last updated: 2024-10-25

cilostazol and Liver Neoplasms

cilostazol has been researched along with Liver Neoplasms in 2 studies

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Cilostazol treatment enhanced the uptake of lipidated apoE3, and this effect was abolished when LRP1 was silenced by siRNA knockdown."1.40The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression. ( Cha, BS; Jeon, BH; Kang, ES; Kim, HJ; Kim, HM; Lee, B; Lee, HC; Moon, JH; Yun, MR, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HJ1
Moon, JH1
Kim, HM1
Yun, MR1
Jeon, BH1
Lee, B1
Kang, ES1
Lee, HC1
Cha, BS1
Strowitzki, MJ1
Dold, S1
von Heesen, M1
Körbel, C1
Scheuer, C1
Moussavian, MR1
Schilling, MK1
Kollmar, O1
Menger, MD1

Other Studies

2 other studies available for cilostazol and Liver Neoplasms

ArticleYear
The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
    Metabolism: clinical and experimental, 2014, Volume: 63, Issue:1

    Topics: Animals; Apolipoprotein E3; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cilostaz

2014
The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.
    Clinical & experimental metastasis, 2014, Volume: 31, Issue:7

    Topics: Animals; Apoptosis; Cell Proliferation; Cilostazol; Colorectal Neoplasms; Exonucleases; Female; Hepa

2014